We are live on ! Find out more
FAS

Formuepleje A/S Portfolio holdings

AUM $1.28B
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+10.62%
1 Year Est. Return
+24.24%
3 Year Est. Return
+75.12%
5 Year Est. Return
+78.91%
10 Year Est. Return
+321.64%
AUM
$2.59B
AUM Growth
-$38.4M
Cap. Flow
-$300M
Cap. Flow %
-11.59%
Top 10 Hldgs %
47.34%
Holding
105
New
7
Increased
29
Reduced
60
Closed
5

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$52.2M
2
AKAM icon
Akamai
AKAM
+$32.2M
3
AMAT icon
Applied Materials
AMAT
+$18.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.6M
5
BABA icon
Alibaba
BABA
+$6.15M

Sector Composition

Rank Sector Weight
1 Technology 23.71%
2 Financials 17.09%
3 Communication Services 14.5%
4 Industrials 13.63%
5 Healthcare 13.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.75T
$202M 7.81%
745,107
-90,314
-11% -$23M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.13T
$154M 5.94%
1,224,980
-402,440
-25% -$48M
ELV icon
3
Elevance Health
ELV
$86.8B
$150M 5.79%
392,329
-150,317
-28% -$57.4M
META icon
4
Meta Platforms (Facebook)
META
$1.45T
$129M 4.98%
370,037
-39,371
-10% -$12.6M
OTIS icon
5
Otis Worldwide
OTIS
$27.2B
$119M 4.62%
1,461,044
-171,220
-10% -$13.2M
AMZN icon
6
Amazon
AMZN
$2.77T
$107M 4.13%
620,600
-47,720
-7% -$7.93M
CTSH icon
7
Cognizant
CTSH
$28.7B
$99.3M 3.84%
1,434,162
-25,324
-2% -$1.89M
AXP icon
8
American Express
AXP
$225B
$91.7M 3.55%
555,094
-44,808
-7% -$7.02M
AMAT icon
9
Applied Materials
AMAT
$380B
$86.9M 3.36%
610,452
+138,526
+29% +$18.6M
MCO icon
10
Moody's
MCO
$88.1B
$86.2M 3.33%
237,808
-33,172
-12% -$11M
BABA icon
11
Alibaba
BABA
$278B
$79.5M 3.07%
350,517
+27,679
+9% +$6.15M
SCI icon
12
Service Corp International
SCI
$11.4B
$73.9M 2.86%
1,379,538
-260,375
-16% -$13.8M
MMM icon
13
3M
MMM
$92.2B
$68.9M 2.67%
415,144
-49,476
-11% -$8.26M
KO icon
14
Coca-Cola
KO
$384B
$68M 2.63%
1,255,794
-180,247
-13% -$9.81M
V icon
15
Visa
V
$709B
$62.8M 2.43%
268,392
-65,933
-20% -$15.1M
DOV icon
16
Dover
DOV
$27.3B
$59.6M 2.31%
395,792
-56,321
-12% -$8.31M
BLK icon
17
Blackrock
BLK
$181B
$58.4M 2.26%
66,784
-8,917
-12% -$7.53M
CMCSA icon
18
Comcast
CMCSA
$94B
$58.1M 2.25%
1,019,235
-131,064
-11% -$7.33M
TMO icon
19
Thermo Fisher Scientific
TMO
$233B
$58.1M 2.25%
115,177
+28,825
+33% +$13.6M
GS icon
20
Goldman Sachs
GS
$303B
$57.6M 2.23%
151,856
-26,976
-15% -$9.65M
AZN icon
21
AstraZeneca
AZN
$255B
$57M 2.2%
+475,790
New +$52.2M
CBRE icon
22
CBRE Group
CBRE
$42.6B
$55.6M 2.15%
648,433
-91,118
-12% -$7.78M
VMW
23
DELISTED
VMware, Inc
VMW
$54.3M 2.1%
339,197
-50,326
-13% -$8.05M
ADP icon
24
Automatic Data Processing
ADP
$113B
$51M 1.97%
256,878
-100,748
-28% -$19.6M
WFC icon
25
Wells Fargo
WFC
$257B
$36.2M 1.4%
798,598
-1,509,281
-65% -$67.4M

Similar funds

Formuepleje A/S's Q2 2021 Portfolio in Review

As of Q2 2021, Formuepleje A/S held 105 positions worth $2.59B, down 1.5% from $2.62B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Formuepleje A/S withdrew a net $300M in Q2 2021, closing 5 positions and reducing 60 holdings. Its most notable exit was Burlington, an estimated $1.09M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Formuepleje A/S opened a new position in AstraZeneca worth $57M.

  • Formuepleje A/S's largest Q2 2021 buy was AstraZeneca: 475,790 shares worth $57M.
  • Formuepleje A/S added most to Applied Materials in Q2 2021, an estimated $18.6M increase.
  • Formuepleje A/S's biggest Q2 2021 reduction was Wells Fargo, cutting an estimated $67.4M.
  • Formuepleje A/S fully exited Burlington in Q2 2021, selling an estimated $1.09M.
  • Formuepleje A/S's ten largest holdings make up 47% of its $2.59B portfolio in Q2 2021.
  • Formuepleje A/S opened 7 new positions and closed 5 in Q2 2021.
  • Formuepleje A/S's portfolio value fell 1.5% quarter-over-quarter to $2.59B.

Based on Formuepleje A/S's 13F filing for Q2 2021, filed 27 Aug 2026.